Growth Medium

Growth Medium Comprehensive Study by Type (Classical Media, Stem Cell Media, Lysogeny Broth, Chemically Defined Media, Specialty Media, Serum-free Media, Others), Application (Cancer Research, Biopharmaceuticals, Tissue Engineering & Regenerative Medicine, Stem Cell Technologies, Drug Discovery, Others), End Use (Biotechnology, Pharmaceutical Industry, Academic Institutions, Research Laboratories, Others), Research (Cytogenetics, Cell Therapy, Others) Players and Region - Global Market Outlook to 2030

Growth Medium Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 6.6%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Growth Medium
A growth medium or culture medium is a solid, liquid or semi-solid designed to support the growth of a population of microorganisms or cells via the process of cell proliferation, or small plants like the moss Physcomitrella patens. The United States growth medium market is expected to grow at a healthy pace during the forecast period, according to the AMA study. Increasing production of biopharmaceutical products and increase in use of techniques across quality control of pharmaceutical products are expected to be some of the major factors aiding the growth of the market. However, the market is expected to witness a decline in growth during FY 2020 but it is again expected to rise at a healthy pace after the COVID-19 pandemic is over.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR6.6%


The vendors in this market are majorly focusing on developing innovative products and solutions in order to cater to the market's demands to remain competitive in the global market. According to the recent global industry crisis due to the outbreak of COVID-19 is expected to be one of the major challenges for the vendors of this market as the production and markets of different industries have been shut down for an ambiguous period of time. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Growth Medium market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Avantor Inc. (United States), Becton, Dickinson and Company (United States), Bio-Rad Laboratories, Inc. (United States), Caisson Laboratories, Inc. (United States), Cell Culture Technologies LLC (Switzerland), Corning Inc. (United States), Fujifilm Holdings Corporation (Japan), GE Healthcare (United States), HiMedia Laboratories (India), Lonza Group AG (Switzerland), Merck & Co., Inc. (United States), Sartorius AG (Germany) and Sera Scandia A/S (Denmark) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Thermo Fisher Scientific (United States) and Vitro Diagnostics, Inc. (Denver).

Segmentation Overview
AMA Research has segmented the market of Global Growth Medium market by Type (Classical Media, Stem Cell Media, Lysogeny Broth, Chemically Defined Media, Specialty Media, Serum-free Media and Others), Application (Cancer Research, Biopharmaceuticals, Tissue Engineering & Regenerative Medicine, Stem Cell Technologies, Drug Discovery and Others) and Region.



On the basis of geography, the market of Growth Medium has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Use, the sub-segment i.e. Biotechnology will boost the Growth Medium market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Research, the sub-segment i.e. Cytogenetics will boost the Growth Medium market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Investments Across Life Sciences Industry

Market Growth Drivers:
Increasing Production of Biopharmaceutical Products, Rise in Use of Techniques Across Quality Control of Pharmaceutical Products and Increasing Demand Owing to Rising Number of Cancer Cases Worldwide

Challenges:
Lack of Skilled Professionals

Restraints:
High Cost of Smart Fridges Hampering the Growth of Market

Opportunities:
Opportunities Across Asia Pacific Region

Market Leaders and their expansionary development strategies
In November 2021,Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, has completed its previously announced acquisition of the Masterflex bioprocessing business and related assets (collectively of Antylia Scientific, a privately held, portfolio company of investment firms GTCR and Golden Gate Capital.
In May 2023 – Lonza has launched the TheraPEAK® T-VIVO® Cell Culture Medium, a novel chemically defined medium developed to optimize CAR T-cell manufacture. Free from animal-origin components, the medium improves consistency and process control, and simplifies regulatory approval for faster time-to-market.
Stringent Government Regulations Regarding Use of Animal-Derived Products in Growth Medium is Impacting the Demand for Growth Medium in the United States

Analyst View
Since the COVID-19 virus outbreak in December 2019, the disease has spread to more than 200 countries across the world along with the World Health Organization declaring it a public health emergency. The impact of the COVID-19 has already hit many industries and will affect the United States growth medium market in FY 2020. The outbreak of COVID-19 has brought effects on many aspects, like scheduled public transportation cancellations; downfall in the real estate sector; travel bans and quarantines; closed operations across hotels & restaurants; banning of public gatherings & events; large slow-down in the supply chain of different markets; stock market unpredictability; declining business assurance, and uncertainty in the future market dynamics.

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Classical Media
  • Stem Cell Media
  • Lysogeny Broth
  • Chemically Defined Media
  • Specialty Media
  • Serum-free Media
  • Others
By Application
  • Cancer Research
  • Biopharmaceuticals
  • Tissue Engineering & Regenerative Medicine
  • Stem Cell Technologies
  • Drug Discovery
  • Others
By End Use
  • Biotechnology
  • Pharmaceutical Industry
  • Academic Institutions
  • Research Laboratories
  • Others

By Research
  • Cytogenetics
  • Cell Therapy
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Production of Biopharmaceutical Products
      • 3.2.2. Rise in Use of Techniques Across Quality Control of Pharmaceutical Products
      • 3.2.3. Increasing Demand Owing to Rising Number of Cancer Cases Worldwide
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Increasing Investments Across Life Sciences Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Growth Medium, by Type, Application, End Use, Research and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Growth Medium (Value)
      • 5.2.1. Global Growth Medium by: Type (Value)
        • 5.2.1.1. Classical Media
        • 5.2.1.2. Stem Cell Media
        • 5.2.1.3. Lysogeny Broth
        • 5.2.1.4. Chemically Defined Media
        • 5.2.1.5. Specialty Media
        • 5.2.1.6. Serum-free Media
        • 5.2.1.7. Others
      • 5.2.2. Global Growth Medium by: Application (Value)
        • 5.2.2.1. Cancer Research
        • 5.2.2.2. Biopharmaceuticals
        • 5.2.2.3. Tissue Engineering & Regenerative Medicine
        • 5.2.2.4. Stem Cell Technologies
        • 5.2.2.5. Drug Discovery
        • 5.2.2.6. Others
      • 5.2.3. Global Growth Medium by: End Use (Value)
        • 5.2.3.1. Biotechnology
        • 5.2.3.2. Pharmaceutical Industry
        • 5.2.3.3. Academic Institutions
        • 5.2.3.4. Research Laboratories
        • 5.2.3.5. Others
      • 5.2.4. Global Growth Medium by: Research (Value)
        • 5.2.4.1. Cytogenetics
        • 5.2.4.2. Cell Therapy
        • 5.2.4.3. Others
      • 5.2.5. Global Growth Medium Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Growth Medium (Volume)
      • 5.3.1. Global Growth Medium by: Type (Volume)
        • 5.3.1.1. Classical Media
        • 5.3.1.2. Stem Cell Media
        • 5.3.1.3. Lysogeny Broth
        • 5.3.1.4. Chemically Defined Media
        • 5.3.1.5. Specialty Media
        • 5.3.1.6. Serum-free Media
        • 5.3.1.7. Others
      • 5.3.2. Global Growth Medium by: Application (Volume)
        • 5.3.2.1. Cancer Research
        • 5.3.2.2. Biopharmaceuticals
        • 5.3.2.3. Tissue Engineering & Regenerative Medicine
        • 5.3.2.4. Stem Cell Technologies
        • 5.3.2.5. Drug Discovery
        • 5.3.2.6. Others
      • 5.3.3. Global Growth Medium by: End Use (Volume)
        • 5.3.3.1. Biotechnology
        • 5.3.3.2. Pharmaceutical Industry
        • 5.3.3.3. Academic Institutions
        • 5.3.3.4. Research Laboratories
        • 5.3.3.5. Others
      • 5.3.4. Global Growth Medium by: Research (Volume)
        • 5.3.4.1. Cytogenetics
        • 5.3.4.2. Cell Therapy
        • 5.3.4.3. Others
      • 5.3.5. Global Growth Medium Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Growth Medium (Price)
      • 5.4.1. Global Growth Medium by: Type (Price)
  • 6. Growth Medium: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Avantor Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Becton, Dickinson and Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Caisson Laboratories, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cell Culture Technologies LLC (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Corning Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Fujifilm Holdings Corporation (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GE Healthcare (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. HiMedia Laboratories (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Lonza Group AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Merck & Co., Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Sartorius AG (Germany)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Sera Scandia A/S (Denmark)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Growth Medium Sale, by Type, Application, End Use, Research and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Growth Medium (Value)
      • 7.2.1. Global Growth Medium by: Type (Value)
        • 7.2.1.1. Classical Media
        • 7.2.1.2. Stem Cell Media
        • 7.2.1.3. Lysogeny Broth
        • 7.2.1.4. Chemically Defined Media
        • 7.2.1.5. Specialty Media
        • 7.2.1.6. Serum-free Media
        • 7.2.1.7. Others
      • 7.2.2. Global Growth Medium by: Application (Value)
        • 7.2.2.1. Cancer Research
        • 7.2.2.2. Biopharmaceuticals
        • 7.2.2.3. Tissue Engineering & Regenerative Medicine
        • 7.2.2.4. Stem Cell Technologies
        • 7.2.2.5. Drug Discovery
        • 7.2.2.6. Others
      • 7.2.3. Global Growth Medium by: End Use (Value)
        • 7.2.3.1. Biotechnology
        • 7.2.3.2. Pharmaceutical Industry
        • 7.2.3.3. Academic Institutions
        • 7.2.3.4. Research Laboratories
        • 7.2.3.5. Others
      • 7.2.4. Global Growth Medium by: Research (Value)
        • 7.2.4.1. Cytogenetics
        • 7.2.4.2. Cell Therapy
        • 7.2.4.3. Others
      • 7.2.5. Global Growth Medium Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Growth Medium (Volume)
      • 7.3.1. Global Growth Medium by: Type (Volume)
        • 7.3.1.1. Classical Media
        • 7.3.1.2. Stem Cell Media
        • 7.3.1.3. Lysogeny Broth
        • 7.3.1.4. Chemically Defined Media
        • 7.3.1.5. Specialty Media
        • 7.3.1.6. Serum-free Media
        • 7.3.1.7. Others
      • 7.3.2. Global Growth Medium by: Application (Volume)
        • 7.3.2.1. Cancer Research
        • 7.3.2.2. Biopharmaceuticals
        • 7.3.2.3. Tissue Engineering & Regenerative Medicine
        • 7.3.2.4. Stem Cell Technologies
        • 7.3.2.5. Drug Discovery
        • 7.3.2.6. Others
      • 7.3.3. Global Growth Medium by: End Use (Volume)
        • 7.3.3.1. Biotechnology
        • 7.3.3.2. Pharmaceutical Industry
        • 7.3.3.3. Academic Institutions
        • 7.3.3.4. Research Laboratories
        • 7.3.3.5. Others
      • 7.3.4. Global Growth Medium by: Research (Volume)
        • 7.3.4.1. Cytogenetics
        • 7.3.4.2. Cell Therapy
        • 7.3.4.3. Others
      • 7.3.5. Global Growth Medium Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Growth Medium (Price)
      • 7.4.1. Global Growth Medium by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Growth Medium: by Type(USD Million)
  • Table 2. Growth Medium Classical Media , by Region USD Million (2018-2023)
  • Table 3. Growth Medium Stem Cell Media , by Region USD Million (2018-2023)
  • Table 4. Growth Medium Lysogeny Broth , by Region USD Million (2018-2023)
  • Table 5. Growth Medium Chemically Defined Media , by Region USD Million (2018-2023)
  • Table 6. Growth Medium Specialty Media , by Region USD Million (2018-2023)
  • Table 7. Growth Medium Serum-free Media , by Region USD Million (2018-2023)
  • Table 8. Growth Medium Others , by Region USD Million (2018-2023)
  • Table 9. Growth Medium: by Application(USD Million)
  • Table 10. Growth Medium Cancer Research , by Region USD Million (2018-2023)
  • Table 11. Growth Medium Biopharmaceuticals , by Region USD Million (2018-2023)
  • Table 12. Growth Medium Tissue Engineering & Regenerative Medicine , by Region USD Million (2018-2023)
  • Table 13. Growth Medium Stem Cell Technologies , by Region USD Million (2018-2023)
  • Table 14. Growth Medium Drug Discovery , by Region USD Million (2018-2023)
  • Table 15. Growth Medium Others , by Region USD Million (2018-2023)
  • Table 16. Growth Medium: by End Use(USD Million)
  • Table 17. Growth Medium Biotechnology , by Region USD Million (2018-2023)
  • Table 18. Growth Medium Pharmaceutical Industry , by Region USD Million (2018-2023)
  • Table 19. Growth Medium Academic Institutions , by Region USD Million (2018-2023)
  • Table 20. Growth Medium Research Laboratories , by Region USD Million (2018-2023)
  • Table 21. Growth Medium Others , by Region USD Million (2018-2023)
  • Table 22. Growth Medium: by Research(USD Million)
  • Table 23. Growth Medium Cytogenetics , by Region USD Million (2018-2023)
  • Table 24. Growth Medium Cell Therapy , by Region USD Million (2018-2023)
  • Table 25. Growth Medium Others , by Region USD Million (2018-2023)
  • Table 26. South America Growth Medium, by Country USD Million (2018-2023)
  • Table 27. South America Growth Medium, by Type USD Million (2018-2023)
  • Table 28. South America Growth Medium, by Application USD Million (2018-2023)
  • Table 29. South America Growth Medium, by End Use USD Million (2018-2023)
  • Table 30. South America Growth Medium, by Research USD Million (2018-2023)
  • Table 31. Brazil Growth Medium, by Type USD Million (2018-2023)
  • Table 32. Brazil Growth Medium, by Application USD Million (2018-2023)
  • Table 33. Brazil Growth Medium, by End Use USD Million (2018-2023)
  • Table 34. Brazil Growth Medium, by Research USD Million (2018-2023)
  • Table 35. Argentina Growth Medium, by Type USD Million (2018-2023)
  • Table 36. Argentina Growth Medium, by Application USD Million (2018-2023)
  • Table 37. Argentina Growth Medium, by End Use USD Million (2018-2023)
  • Table 38. Argentina Growth Medium, by Research USD Million (2018-2023)
  • Table 39. Rest of South America Growth Medium, by Type USD Million (2018-2023)
  • Table 40. Rest of South America Growth Medium, by Application USD Million (2018-2023)
  • Table 41. Rest of South America Growth Medium, by End Use USD Million (2018-2023)
  • Table 42. Rest of South America Growth Medium, by Research USD Million (2018-2023)
  • Table 43. Asia Pacific Growth Medium, by Country USD Million (2018-2023)
  • Table 44. Asia Pacific Growth Medium, by Type USD Million (2018-2023)
  • Table 45. Asia Pacific Growth Medium, by Application USD Million (2018-2023)
  • Table 46. Asia Pacific Growth Medium, by End Use USD Million (2018-2023)
  • Table 47. Asia Pacific Growth Medium, by Research USD Million (2018-2023)
  • Table 48. China Growth Medium, by Type USD Million (2018-2023)
  • Table 49. China Growth Medium, by Application USD Million (2018-2023)
  • Table 50. China Growth Medium, by End Use USD Million (2018-2023)
  • Table 51. China Growth Medium, by Research USD Million (2018-2023)
  • Table 52. Japan Growth Medium, by Type USD Million (2018-2023)
  • Table 53. Japan Growth Medium, by Application USD Million (2018-2023)
  • Table 54. Japan Growth Medium, by End Use USD Million (2018-2023)
  • Table 55. Japan Growth Medium, by Research USD Million (2018-2023)
  • Table 56. India Growth Medium, by Type USD Million (2018-2023)
  • Table 57. India Growth Medium, by Application USD Million (2018-2023)
  • Table 58. India Growth Medium, by End Use USD Million (2018-2023)
  • Table 59. India Growth Medium, by Research USD Million (2018-2023)
  • Table 60. South Korea Growth Medium, by Type USD Million (2018-2023)
  • Table 61. South Korea Growth Medium, by Application USD Million (2018-2023)
  • Table 62. South Korea Growth Medium, by End Use USD Million (2018-2023)
  • Table 63. South Korea Growth Medium, by Research USD Million (2018-2023)
  • Table 64. Taiwan Growth Medium, by Type USD Million (2018-2023)
  • Table 65. Taiwan Growth Medium, by Application USD Million (2018-2023)
  • Table 66. Taiwan Growth Medium, by End Use USD Million (2018-2023)
  • Table 67. Taiwan Growth Medium, by Research USD Million (2018-2023)
  • Table 68. Australia Growth Medium, by Type USD Million (2018-2023)
  • Table 69. Australia Growth Medium, by Application USD Million (2018-2023)
  • Table 70. Australia Growth Medium, by End Use USD Million (2018-2023)
  • Table 71. Australia Growth Medium, by Research USD Million (2018-2023)
  • Table 72. Rest of Asia-Pacific Growth Medium, by Type USD Million (2018-2023)
  • Table 73. Rest of Asia-Pacific Growth Medium, by Application USD Million (2018-2023)
  • Table 74. Rest of Asia-Pacific Growth Medium, by End Use USD Million (2018-2023)
  • Table 75. Rest of Asia-Pacific Growth Medium, by Research USD Million (2018-2023)
  • Table 76. Europe Growth Medium, by Country USD Million (2018-2023)
  • Table 77. Europe Growth Medium, by Type USD Million (2018-2023)
  • Table 78. Europe Growth Medium, by Application USD Million (2018-2023)
  • Table 79. Europe Growth Medium, by End Use USD Million (2018-2023)
  • Table 80. Europe Growth Medium, by Research USD Million (2018-2023)
  • Table 81. Germany Growth Medium, by Type USD Million (2018-2023)
  • Table 82. Germany Growth Medium, by Application USD Million (2018-2023)
  • Table 83. Germany Growth Medium, by End Use USD Million (2018-2023)
  • Table 84. Germany Growth Medium, by Research USD Million (2018-2023)
  • Table 85. France Growth Medium, by Type USD Million (2018-2023)
  • Table 86. France Growth Medium, by Application USD Million (2018-2023)
  • Table 87. France Growth Medium, by End Use USD Million (2018-2023)
  • Table 88. France Growth Medium, by Research USD Million (2018-2023)
  • Table 89. Italy Growth Medium, by Type USD Million (2018-2023)
  • Table 90. Italy Growth Medium, by Application USD Million (2018-2023)
  • Table 91. Italy Growth Medium, by End Use USD Million (2018-2023)
  • Table 92. Italy Growth Medium, by Research USD Million (2018-2023)
  • Table 93. United Kingdom Growth Medium, by Type USD Million (2018-2023)
  • Table 94. United Kingdom Growth Medium, by Application USD Million (2018-2023)
  • Table 95. United Kingdom Growth Medium, by End Use USD Million (2018-2023)
  • Table 96. United Kingdom Growth Medium, by Research USD Million (2018-2023)
  • Table 97. Netherlands Growth Medium, by Type USD Million (2018-2023)
  • Table 98. Netherlands Growth Medium, by Application USD Million (2018-2023)
  • Table 99. Netherlands Growth Medium, by End Use USD Million (2018-2023)
  • Table 100. Netherlands Growth Medium, by Research USD Million (2018-2023)
  • Table 101. Rest of Europe Growth Medium, by Type USD Million (2018-2023)
  • Table 102. Rest of Europe Growth Medium, by Application USD Million (2018-2023)
  • Table 103. Rest of Europe Growth Medium, by End Use USD Million (2018-2023)
  • Table 104. Rest of Europe Growth Medium, by Research USD Million (2018-2023)
  • Table 105. MEA Growth Medium, by Country USD Million (2018-2023)
  • Table 106. MEA Growth Medium, by Type USD Million (2018-2023)
  • Table 107. MEA Growth Medium, by Application USD Million (2018-2023)
  • Table 108. MEA Growth Medium, by End Use USD Million (2018-2023)
  • Table 109. MEA Growth Medium, by Research USD Million (2018-2023)
  • Table 110. Middle East Growth Medium, by Type USD Million (2018-2023)
  • Table 111. Middle East Growth Medium, by Application USD Million (2018-2023)
  • Table 112. Middle East Growth Medium, by End Use USD Million (2018-2023)
  • Table 113. Middle East Growth Medium, by Research USD Million (2018-2023)
  • Table 114. Africa Growth Medium, by Type USD Million (2018-2023)
  • Table 115. Africa Growth Medium, by Application USD Million (2018-2023)
  • Table 116. Africa Growth Medium, by End Use USD Million (2018-2023)
  • Table 117. Africa Growth Medium, by Research USD Million (2018-2023)
  • Table 118. North America Growth Medium, by Country USD Million (2018-2023)
  • Table 119. North America Growth Medium, by Type USD Million (2018-2023)
  • Table 120. North America Growth Medium, by Application USD Million (2018-2023)
  • Table 121. North America Growth Medium, by End Use USD Million (2018-2023)
  • Table 122. North America Growth Medium, by Research USD Million (2018-2023)
  • Table 123. United States Growth Medium, by Type USD Million (2018-2023)
  • Table 124. United States Growth Medium, by Application USD Million (2018-2023)
  • Table 125. United States Growth Medium, by End Use USD Million (2018-2023)
  • Table 126. United States Growth Medium, by Research USD Million (2018-2023)
  • Table 127. Canada Growth Medium, by Type USD Million (2018-2023)
  • Table 128. Canada Growth Medium, by Application USD Million (2018-2023)
  • Table 129. Canada Growth Medium, by End Use USD Million (2018-2023)
  • Table 130. Canada Growth Medium, by Research USD Million (2018-2023)
  • Table 131. Mexico Growth Medium, by Type USD Million (2018-2023)
  • Table 132. Mexico Growth Medium, by Application USD Million (2018-2023)
  • Table 133. Mexico Growth Medium, by End Use USD Million (2018-2023)
  • Table 134. Mexico Growth Medium, by Research USD Million (2018-2023)
  • Table 135. Growth Medium Sales: by Type(K Units)
  • Table 136. Growth Medium Sales Classical Media , by Region K Units (2018-2023)
  • Table 137. Growth Medium Sales Stem Cell Media , by Region K Units (2018-2023)
  • Table 138. Growth Medium Sales Lysogeny Broth , by Region K Units (2018-2023)
  • Table 139. Growth Medium Sales Chemically Defined Media , by Region K Units (2018-2023)
  • Table 140. Growth Medium Sales Specialty Media , by Region K Units (2018-2023)
  • Table 141. Growth Medium Sales Serum-free Media , by Region K Units (2018-2023)
  • Table 142. Growth Medium Sales Others , by Region K Units (2018-2023)
  • Table 143. Growth Medium Sales: by Application(K Units)
  • Table 144. Growth Medium Sales Cancer Research , by Region K Units (2018-2023)
  • Table 145. Growth Medium Sales Biopharmaceuticals , by Region K Units (2018-2023)
  • Table 146. Growth Medium Sales Tissue Engineering & Regenerative Medicine , by Region K Units (2018-2023)
  • Table 147. Growth Medium Sales Stem Cell Technologies , by Region K Units (2018-2023)
  • Table 148. Growth Medium Sales Drug Discovery , by Region K Units (2018-2023)
  • Table 149. Growth Medium Sales Others , by Region K Units (2018-2023)
  • Table 150. Growth Medium Sales: by End Use(K Units)
  • Table 151. Growth Medium Sales Biotechnology , by Region K Units (2018-2023)
  • Table 152. Growth Medium Sales Pharmaceutical Industry , by Region K Units (2018-2023)
  • Table 153. Growth Medium Sales Academic Institutions , by Region K Units (2018-2023)
  • Table 154. Growth Medium Sales Research Laboratories , by Region K Units (2018-2023)
  • Table 155. Growth Medium Sales Others , by Region K Units (2018-2023)
  • Table 156. Growth Medium Sales: by Research(K Units)
  • Table 157. Growth Medium Sales Cytogenetics , by Region K Units (2018-2023)
  • Table 158. Growth Medium Sales Cell Therapy , by Region K Units (2018-2023)
  • Table 159. Growth Medium Sales Others , by Region K Units (2018-2023)
  • Table 160. South America Growth Medium Sales, by Country K Units (2018-2023)
  • Table 161. South America Growth Medium Sales, by Type K Units (2018-2023)
  • Table 162. South America Growth Medium Sales, by Application K Units (2018-2023)
  • Table 163. South America Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 164. South America Growth Medium Sales, by Research K Units (2018-2023)
  • Table 165. Brazil Growth Medium Sales, by Type K Units (2018-2023)
  • Table 166. Brazil Growth Medium Sales, by Application K Units (2018-2023)
  • Table 167. Brazil Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 168. Brazil Growth Medium Sales, by Research K Units (2018-2023)
  • Table 169. Argentina Growth Medium Sales, by Type K Units (2018-2023)
  • Table 170. Argentina Growth Medium Sales, by Application K Units (2018-2023)
  • Table 171. Argentina Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 172. Argentina Growth Medium Sales, by Research K Units (2018-2023)
  • Table 173. Rest of South America Growth Medium Sales, by Type K Units (2018-2023)
  • Table 174. Rest of South America Growth Medium Sales, by Application K Units (2018-2023)
  • Table 175. Rest of South America Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 176. Rest of South America Growth Medium Sales, by Research K Units (2018-2023)
  • Table 177. Asia Pacific Growth Medium Sales, by Country K Units (2018-2023)
  • Table 178. Asia Pacific Growth Medium Sales, by Type K Units (2018-2023)
  • Table 179. Asia Pacific Growth Medium Sales, by Application K Units (2018-2023)
  • Table 180. Asia Pacific Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 181. Asia Pacific Growth Medium Sales, by Research K Units (2018-2023)
  • Table 182. China Growth Medium Sales, by Type K Units (2018-2023)
  • Table 183. China Growth Medium Sales, by Application K Units (2018-2023)
  • Table 184. China Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 185. China Growth Medium Sales, by Research K Units (2018-2023)
  • Table 186. Japan Growth Medium Sales, by Type K Units (2018-2023)
  • Table 187. Japan Growth Medium Sales, by Application K Units (2018-2023)
  • Table 188. Japan Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 189. Japan Growth Medium Sales, by Research K Units (2018-2023)
  • Table 190. India Growth Medium Sales, by Type K Units (2018-2023)
  • Table 191. India Growth Medium Sales, by Application K Units (2018-2023)
  • Table 192. India Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 193. India Growth Medium Sales, by Research K Units (2018-2023)
  • Table 194. South Korea Growth Medium Sales, by Type K Units (2018-2023)
  • Table 195. South Korea Growth Medium Sales, by Application K Units (2018-2023)
  • Table 196. South Korea Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 197. South Korea Growth Medium Sales, by Research K Units (2018-2023)
  • Table 198. Taiwan Growth Medium Sales, by Type K Units (2018-2023)
  • Table 199. Taiwan Growth Medium Sales, by Application K Units (2018-2023)
  • Table 200. Taiwan Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 201. Taiwan Growth Medium Sales, by Research K Units (2018-2023)
  • Table 202. Australia Growth Medium Sales, by Type K Units (2018-2023)
  • Table 203. Australia Growth Medium Sales, by Application K Units (2018-2023)
  • Table 204. Australia Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 205. Australia Growth Medium Sales, by Research K Units (2018-2023)
  • Table 206. Rest of Asia-Pacific Growth Medium Sales, by Type K Units (2018-2023)
  • Table 207. Rest of Asia-Pacific Growth Medium Sales, by Application K Units (2018-2023)
  • Table 208. Rest of Asia-Pacific Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 209. Rest of Asia-Pacific Growth Medium Sales, by Research K Units (2018-2023)
  • Table 210. Europe Growth Medium Sales, by Country K Units (2018-2023)
  • Table 211. Europe Growth Medium Sales, by Type K Units (2018-2023)
  • Table 212. Europe Growth Medium Sales, by Application K Units (2018-2023)
  • Table 213. Europe Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 214. Europe Growth Medium Sales, by Research K Units (2018-2023)
  • Table 215. Germany Growth Medium Sales, by Type K Units (2018-2023)
  • Table 216. Germany Growth Medium Sales, by Application K Units (2018-2023)
  • Table 217. Germany Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 218. Germany Growth Medium Sales, by Research K Units (2018-2023)
  • Table 219. France Growth Medium Sales, by Type K Units (2018-2023)
  • Table 220. France Growth Medium Sales, by Application K Units (2018-2023)
  • Table 221. France Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 222. France Growth Medium Sales, by Research K Units (2018-2023)
  • Table 223. Italy Growth Medium Sales, by Type K Units (2018-2023)
  • Table 224. Italy Growth Medium Sales, by Application K Units (2018-2023)
  • Table 225. Italy Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 226. Italy Growth Medium Sales, by Research K Units (2018-2023)
  • Table 227. United Kingdom Growth Medium Sales, by Type K Units (2018-2023)
  • Table 228. United Kingdom Growth Medium Sales, by Application K Units (2018-2023)
  • Table 229. United Kingdom Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 230. United Kingdom Growth Medium Sales, by Research K Units (2018-2023)
  • Table 231. Netherlands Growth Medium Sales, by Type K Units (2018-2023)
  • Table 232. Netherlands Growth Medium Sales, by Application K Units (2018-2023)
  • Table 233. Netherlands Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 234. Netherlands Growth Medium Sales, by Research K Units (2018-2023)
  • Table 235. Rest of Europe Growth Medium Sales, by Type K Units (2018-2023)
  • Table 236. Rest of Europe Growth Medium Sales, by Application K Units (2018-2023)
  • Table 237. Rest of Europe Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 238. Rest of Europe Growth Medium Sales, by Research K Units (2018-2023)
  • Table 239. MEA Growth Medium Sales, by Country K Units (2018-2023)
  • Table 240. MEA Growth Medium Sales, by Type K Units (2018-2023)
  • Table 241. MEA Growth Medium Sales, by Application K Units (2018-2023)
  • Table 242. MEA Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 243. MEA Growth Medium Sales, by Research K Units (2018-2023)
  • Table 244. Middle East Growth Medium Sales, by Type K Units (2018-2023)
  • Table 245. Middle East Growth Medium Sales, by Application K Units (2018-2023)
  • Table 246. Middle East Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 247. Middle East Growth Medium Sales, by Research K Units (2018-2023)
  • Table 248. Africa Growth Medium Sales, by Type K Units (2018-2023)
  • Table 249. Africa Growth Medium Sales, by Application K Units (2018-2023)
  • Table 250. Africa Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 251. Africa Growth Medium Sales, by Research K Units (2018-2023)
  • Table 252. North America Growth Medium Sales, by Country K Units (2018-2023)
  • Table 253. North America Growth Medium Sales, by Type K Units (2018-2023)
  • Table 254. North America Growth Medium Sales, by Application K Units (2018-2023)
  • Table 255. North America Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 256. North America Growth Medium Sales, by Research K Units (2018-2023)
  • Table 257. United States Growth Medium Sales, by Type K Units (2018-2023)
  • Table 258. United States Growth Medium Sales, by Application K Units (2018-2023)
  • Table 259. United States Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 260. United States Growth Medium Sales, by Research K Units (2018-2023)
  • Table 261. Canada Growth Medium Sales, by Type K Units (2018-2023)
  • Table 262. Canada Growth Medium Sales, by Application K Units (2018-2023)
  • Table 263. Canada Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 264. Canada Growth Medium Sales, by Research K Units (2018-2023)
  • Table 265. Mexico Growth Medium Sales, by Type K Units (2018-2023)
  • Table 266. Mexico Growth Medium Sales, by Application K Units (2018-2023)
  • Table 267. Mexico Growth Medium Sales, by End Use K Units (2018-2023)
  • Table 268. Mexico Growth Medium Sales, by Research K Units (2018-2023)
  • Table 269. Growth Medium: by Type(USD/Units)
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Company Basic Information, Sales Area and Its Competitors
  • Table 273. Company Basic Information, Sales Area and Its Competitors
  • Table 274. Company Basic Information, Sales Area and Its Competitors
  • Table 275. Company Basic Information, Sales Area and Its Competitors
  • Table 276. Company Basic Information, Sales Area and Its Competitors
  • Table 277. Company Basic Information, Sales Area and Its Competitors
  • Table 278. Company Basic Information, Sales Area and Its Competitors
  • Table 279. Company Basic Information, Sales Area and Its Competitors
  • Table 280. Company Basic Information, Sales Area and Its Competitors
  • Table 281. Company Basic Information, Sales Area and Its Competitors
  • Table 282. Company Basic Information, Sales Area and Its Competitors
  • Table 283. Growth Medium: by Type(USD Million)
  • Table 284. Growth Medium Classical Media , by Region USD Million (2025-2030)
  • Table 285. Growth Medium Stem Cell Media , by Region USD Million (2025-2030)
  • Table 286. Growth Medium Lysogeny Broth , by Region USD Million (2025-2030)
  • Table 287. Growth Medium Chemically Defined Media , by Region USD Million (2025-2030)
  • Table 288. Growth Medium Specialty Media , by Region USD Million (2025-2030)
  • Table 289. Growth Medium Serum-free Media , by Region USD Million (2025-2030)
  • Table 290. Growth Medium Others , by Region USD Million (2025-2030)
  • Table 291. Growth Medium: by Application(USD Million)
  • Table 292. Growth Medium Cancer Research , by Region USD Million (2025-2030)
  • Table 293. Growth Medium Biopharmaceuticals , by Region USD Million (2025-2030)
  • Table 294. Growth Medium Tissue Engineering & Regenerative Medicine , by Region USD Million (2025-2030)
  • Table 295. Growth Medium Stem Cell Technologies , by Region USD Million (2025-2030)
  • Table 296. Growth Medium Drug Discovery , by Region USD Million (2025-2030)
  • Table 297. Growth Medium Others , by Region USD Million (2025-2030)
  • Table 298. Growth Medium: by End Use(USD Million)
  • Table 299. Growth Medium Biotechnology , by Region USD Million (2025-2030)
  • Table 300. Growth Medium Pharmaceutical Industry , by Region USD Million (2025-2030)
  • Table 301. Growth Medium Academic Institutions , by Region USD Million (2025-2030)
  • Table 302. Growth Medium Research Laboratories , by Region USD Million (2025-2030)
  • Table 303. Growth Medium Others , by Region USD Million (2025-2030)
  • Table 304. Growth Medium: by Research(USD Million)
  • Table 305. Growth Medium Cytogenetics , by Region USD Million (2025-2030)
  • Table 306. Growth Medium Cell Therapy , by Region USD Million (2025-2030)
  • Table 307. Growth Medium Others , by Region USD Million (2025-2030)
  • Table 308. South America Growth Medium, by Country USD Million (2025-2030)
  • Table 309. South America Growth Medium, by Type USD Million (2025-2030)
  • Table 310. South America Growth Medium, by Application USD Million (2025-2030)
  • Table 311. South America Growth Medium, by End Use USD Million (2025-2030)
  • Table 312. South America Growth Medium, by Research USD Million (2025-2030)
  • Table 313. Brazil Growth Medium, by Type USD Million (2025-2030)
  • Table 314. Brazil Growth Medium, by Application USD Million (2025-2030)
  • Table 315. Brazil Growth Medium, by End Use USD Million (2025-2030)
  • Table 316. Brazil Growth Medium, by Research USD Million (2025-2030)
  • Table 317. Argentina Growth Medium, by Type USD Million (2025-2030)
  • Table 318. Argentina Growth Medium, by Application USD Million (2025-2030)
  • Table 319. Argentina Growth Medium, by End Use USD Million (2025-2030)
  • Table 320. Argentina Growth Medium, by Research USD Million (2025-2030)
  • Table 321. Rest of South America Growth Medium, by Type USD Million (2025-2030)
  • Table 322. Rest of South America Growth Medium, by Application USD Million (2025-2030)
  • Table 323. Rest of South America Growth Medium, by End Use USD Million (2025-2030)
  • Table 324. Rest of South America Growth Medium, by Research USD Million (2025-2030)
  • Table 325. Asia Pacific Growth Medium, by Country USD Million (2025-2030)
  • Table 326. Asia Pacific Growth Medium, by Type USD Million (2025-2030)
  • Table 327. Asia Pacific Growth Medium, by Application USD Million (2025-2030)
  • Table 328. Asia Pacific Growth Medium, by End Use USD Million (2025-2030)
  • Table 329. Asia Pacific Growth Medium, by Research USD Million (2025-2030)
  • Table 330. China Growth Medium, by Type USD Million (2025-2030)
  • Table 331. China Growth Medium, by Application USD Million (2025-2030)
  • Table 332. China Growth Medium, by End Use USD Million (2025-2030)
  • Table 333. China Growth Medium, by Research USD Million (2025-2030)
  • Table 334. Japan Growth Medium, by Type USD Million (2025-2030)
  • Table 335. Japan Growth Medium, by Application USD Million (2025-2030)
  • Table 336. Japan Growth Medium, by End Use USD Million (2025-2030)
  • Table 337. Japan Growth Medium, by Research USD Million (2025-2030)
  • Table 338. India Growth Medium, by Type USD Million (2025-2030)
  • Table 339. India Growth Medium, by Application USD Million (2025-2030)
  • Table 340. India Growth Medium, by End Use USD Million (2025-2030)
  • Table 341. India Growth Medium, by Research USD Million (2025-2030)
  • Table 342. South Korea Growth Medium, by Type USD Million (2025-2030)
  • Table 343. South Korea Growth Medium, by Application USD Million (2025-2030)
  • Table 344. South Korea Growth Medium, by End Use USD Million (2025-2030)
  • Table 345. South Korea Growth Medium, by Research USD Million (2025-2030)
  • Table 346. Taiwan Growth Medium, by Type USD Million (2025-2030)
  • Table 347. Taiwan Growth Medium, by Application USD Million (2025-2030)
  • Table 348. Taiwan Growth Medium, by End Use USD Million (2025-2030)
  • Table 349. Taiwan Growth Medium, by Research USD Million (2025-2030)
  • Table 350. Australia Growth Medium, by Type USD Million (2025-2030)
  • Table 351. Australia Growth Medium, by Application USD Million (2025-2030)
  • Table 352. Australia Growth Medium, by End Use USD Million (2025-2030)
  • Table 353. Australia Growth Medium, by Research USD Million (2025-2030)
  • Table 354. Rest of Asia-Pacific Growth Medium, by Type USD Million (2025-2030)
  • Table 355. Rest of Asia-Pacific Growth Medium, by Application USD Million (2025-2030)
  • Table 356. Rest of Asia-Pacific Growth Medium, by End Use USD Million (2025-2030)
  • Table 357. Rest of Asia-Pacific Growth Medium, by Research USD Million (2025-2030)
  • Table 358. Europe Growth Medium, by Country USD Million (2025-2030)
  • Table 359. Europe Growth Medium, by Type USD Million (2025-2030)
  • Table 360. Europe Growth Medium, by Application USD Million (2025-2030)
  • Table 361. Europe Growth Medium, by End Use USD Million (2025-2030)
  • Table 362. Europe Growth Medium, by Research USD Million (2025-2030)
  • Table 363. Germany Growth Medium, by Type USD Million (2025-2030)
  • Table 364. Germany Growth Medium, by Application USD Million (2025-2030)
  • Table 365. Germany Growth Medium, by End Use USD Million (2025-2030)
  • Table 366. Germany Growth Medium, by Research USD Million (2025-2030)
  • Table 367. France Growth Medium, by Type USD Million (2025-2030)
  • Table 368. France Growth Medium, by Application USD Million (2025-2030)
  • Table 369. France Growth Medium, by End Use USD Million (2025-2030)
  • Table 370. France Growth Medium, by Research USD Million (2025-2030)
  • Table 371. Italy Growth Medium, by Type USD Million (2025-2030)
  • Table 372. Italy Growth Medium, by Application USD Million (2025-2030)
  • Table 373. Italy Growth Medium, by End Use USD Million (2025-2030)
  • Table 374. Italy Growth Medium, by Research USD Million (2025-2030)
  • Table 375. United Kingdom Growth Medium, by Type USD Million (2025-2030)
  • Table 376. United Kingdom Growth Medium, by Application USD Million (2025-2030)
  • Table 377. United Kingdom Growth Medium, by End Use USD Million (2025-2030)
  • Table 378. United Kingdom Growth Medium, by Research USD Million (2025-2030)
  • Table 379. Netherlands Growth Medium, by Type USD Million (2025-2030)
  • Table 380. Netherlands Growth Medium, by Application USD Million (2025-2030)
  • Table 381. Netherlands Growth Medium, by End Use USD Million (2025-2030)
  • Table 382. Netherlands Growth Medium, by Research USD Million (2025-2030)
  • Table 383. Rest of Europe Growth Medium, by Type USD Million (2025-2030)
  • Table 384. Rest of Europe Growth Medium, by Application USD Million (2025-2030)
  • Table 385. Rest of Europe Growth Medium, by End Use USD Million (2025-2030)
  • Table 386. Rest of Europe Growth Medium, by Research USD Million (2025-2030)
  • Table 387. MEA Growth Medium, by Country USD Million (2025-2030)
  • Table 388. MEA Growth Medium, by Type USD Million (2025-2030)
  • Table 389. MEA Growth Medium, by Application USD Million (2025-2030)
  • Table 390. MEA Growth Medium, by End Use USD Million (2025-2030)
  • Table 391. MEA Growth Medium, by Research USD Million (2025-2030)
  • Table 392. Middle East Growth Medium, by Type USD Million (2025-2030)
  • Table 393. Middle East Growth Medium, by Application USD Million (2025-2030)
  • Table 394. Middle East Growth Medium, by End Use USD Million (2025-2030)
  • Table 395. Middle East Growth Medium, by Research USD Million (2025-2030)
  • Table 396. Africa Growth Medium, by Type USD Million (2025-2030)
  • Table 397. Africa Growth Medium, by Application USD Million (2025-2030)
  • Table 398. Africa Growth Medium, by End Use USD Million (2025-2030)
  • Table 399. Africa Growth Medium, by Research USD Million (2025-2030)
  • Table 400. North America Growth Medium, by Country USD Million (2025-2030)
  • Table 401. North America Growth Medium, by Type USD Million (2025-2030)
  • Table 402. North America Growth Medium, by Application USD Million (2025-2030)
  • Table 403. North America Growth Medium, by End Use USD Million (2025-2030)
  • Table 404. North America Growth Medium, by Research USD Million (2025-2030)
  • Table 405. United States Growth Medium, by Type USD Million (2025-2030)
  • Table 406. United States Growth Medium, by Application USD Million (2025-2030)
  • Table 407. United States Growth Medium, by End Use USD Million (2025-2030)
  • Table 408. United States Growth Medium, by Research USD Million (2025-2030)
  • Table 409. Canada Growth Medium, by Type USD Million (2025-2030)
  • Table 410. Canada Growth Medium, by Application USD Million (2025-2030)
  • Table 411. Canada Growth Medium, by End Use USD Million (2025-2030)
  • Table 412. Canada Growth Medium, by Research USD Million (2025-2030)
  • Table 413. Mexico Growth Medium, by Type USD Million (2025-2030)
  • Table 414. Mexico Growth Medium, by Application USD Million (2025-2030)
  • Table 415. Mexico Growth Medium, by End Use USD Million (2025-2030)
  • Table 416. Mexico Growth Medium, by Research USD Million (2025-2030)
  • Table 417. Growth Medium Sales: by Type(K Units)
  • Table 418. Growth Medium Sales Classical Media , by Region K Units (2025-2030)
  • Table 419. Growth Medium Sales Stem Cell Media , by Region K Units (2025-2030)
  • Table 420. Growth Medium Sales Lysogeny Broth , by Region K Units (2025-2030)
  • Table 421. Growth Medium Sales Chemically Defined Media , by Region K Units (2025-2030)
  • Table 422. Growth Medium Sales Specialty Media , by Region K Units (2025-2030)
  • Table 423. Growth Medium Sales Serum-free Media , by Region K Units (2025-2030)
  • Table 424. Growth Medium Sales Others , by Region K Units (2025-2030)
  • Table 425. Growth Medium Sales: by Application(K Units)
  • Table 426. Growth Medium Sales Cancer Research , by Region K Units (2025-2030)
  • Table 427. Growth Medium Sales Biopharmaceuticals , by Region K Units (2025-2030)
  • Table 428. Growth Medium Sales Tissue Engineering & Regenerative Medicine , by Region K Units (2025-2030)
  • Table 429. Growth Medium Sales Stem Cell Technologies , by Region K Units (2025-2030)
  • Table 430. Growth Medium Sales Drug Discovery , by Region K Units (2025-2030)
  • Table 431. Growth Medium Sales Others , by Region K Units (2025-2030)
  • Table 432. Growth Medium Sales: by End Use(K Units)
  • Table 433. Growth Medium Sales Biotechnology , by Region K Units (2025-2030)
  • Table 434. Growth Medium Sales Pharmaceutical Industry , by Region K Units (2025-2030)
  • Table 435. Growth Medium Sales Academic Institutions , by Region K Units (2025-2030)
  • Table 436. Growth Medium Sales Research Laboratories , by Region K Units (2025-2030)
  • Table 437. Growth Medium Sales Others , by Region K Units (2025-2030)
  • Table 438. Growth Medium Sales: by Research(K Units)
  • Table 439. Growth Medium Sales Cytogenetics , by Region K Units (2025-2030)
  • Table 440. Growth Medium Sales Cell Therapy , by Region K Units (2025-2030)
  • Table 441. Growth Medium Sales Others , by Region K Units (2025-2030)
  • Table 442. South America Growth Medium Sales, by Country K Units (2025-2030)
  • Table 443. South America Growth Medium Sales, by Type K Units (2025-2030)
  • Table 444. South America Growth Medium Sales, by Application K Units (2025-2030)
  • Table 445. South America Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 446. South America Growth Medium Sales, by Research K Units (2025-2030)
  • Table 447. Brazil Growth Medium Sales, by Type K Units (2025-2030)
  • Table 448. Brazil Growth Medium Sales, by Application K Units (2025-2030)
  • Table 449. Brazil Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 450. Brazil Growth Medium Sales, by Research K Units (2025-2030)
  • Table 451. Argentina Growth Medium Sales, by Type K Units (2025-2030)
  • Table 452. Argentina Growth Medium Sales, by Application K Units (2025-2030)
  • Table 453. Argentina Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 454. Argentina Growth Medium Sales, by Research K Units (2025-2030)
  • Table 455. Rest of South America Growth Medium Sales, by Type K Units (2025-2030)
  • Table 456. Rest of South America Growth Medium Sales, by Application K Units (2025-2030)
  • Table 457. Rest of South America Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 458. Rest of South America Growth Medium Sales, by Research K Units (2025-2030)
  • Table 459. Asia Pacific Growth Medium Sales, by Country K Units (2025-2030)
  • Table 460. Asia Pacific Growth Medium Sales, by Type K Units (2025-2030)
  • Table 461. Asia Pacific Growth Medium Sales, by Application K Units (2025-2030)
  • Table 462. Asia Pacific Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 463. Asia Pacific Growth Medium Sales, by Research K Units (2025-2030)
  • Table 464. China Growth Medium Sales, by Type K Units (2025-2030)
  • Table 465. China Growth Medium Sales, by Application K Units (2025-2030)
  • Table 466. China Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 467. China Growth Medium Sales, by Research K Units (2025-2030)
  • Table 468. Japan Growth Medium Sales, by Type K Units (2025-2030)
  • Table 469. Japan Growth Medium Sales, by Application K Units (2025-2030)
  • Table 470. Japan Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 471. Japan Growth Medium Sales, by Research K Units (2025-2030)
  • Table 472. India Growth Medium Sales, by Type K Units (2025-2030)
  • Table 473. India Growth Medium Sales, by Application K Units (2025-2030)
  • Table 474. India Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 475. India Growth Medium Sales, by Research K Units (2025-2030)
  • Table 476. South Korea Growth Medium Sales, by Type K Units (2025-2030)
  • Table 477. South Korea Growth Medium Sales, by Application K Units (2025-2030)
  • Table 478. South Korea Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 479. South Korea Growth Medium Sales, by Research K Units (2025-2030)
  • Table 480. Taiwan Growth Medium Sales, by Type K Units (2025-2030)
  • Table 481. Taiwan Growth Medium Sales, by Application K Units (2025-2030)
  • Table 482. Taiwan Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 483. Taiwan Growth Medium Sales, by Research K Units (2025-2030)
  • Table 484. Australia Growth Medium Sales, by Type K Units (2025-2030)
  • Table 485. Australia Growth Medium Sales, by Application K Units (2025-2030)
  • Table 486. Australia Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 487. Australia Growth Medium Sales, by Research K Units (2025-2030)
  • Table 488. Rest of Asia-Pacific Growth Medium Sales, by Type K Units (2025-2030)
  • Table 489. Rest of Asia-Pacific Growth Medium Sales, by Application K Units (2025-2030)
  • Table 490. Rest of Asia-Pacific Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 491. Rest of Asia-Pacific Growth Medium Sales, by Research K Units (2025-2030)
  • Table 492. Europe Growth Medium Sales, by Country K Units (2025-2030)
  • Table 493. Europe Growth Medium Sales, by Type K Units (2025-2030)
  • Table 494. Europe Growth Medium Sales, by Application K Units (2025-2030)
  • Table 495. Europe Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 496. Europe Growth Medium Sales, by Research K Units (2025-2030)
  • Table 497. Germany Growth Medium Sales, by Type K Units (2025-2030)
  • Table 498. Germany Growth Medium Sales, by Application K Units (2025-2030)
  • Table 499. Germany Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 500. Germany Growth Medium Sales, by Research K Units (2025-2030)
  • Table 501. France Growth Medium Sales, by Type K Units (2025-2030)
  • Table 502. France Growth Medium Sales, by Application K Units (2025-2030)
  • Table 503. France Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 504. France Growth Medium Sales, by Research K Units (2025-2030)
  • Table 505. Italy Growth Medium Sales, by Type K Units (2025-2030)
  • Table 506. Italy Growth Medium Sales, by Application K Units (2025-2030)
  • Table 507. Italy Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 508. Italy Growth Medium Sales, by Research K Units (2025-2030)
  • Table 509. United Kingdom Growth Medium Sales, by Type K Units (2025-2030)
  • Table 510. United Kingdom Growth Medium Sales, by Application K Units (2025-2030)
  • Table 511. United Kingdom Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 512. United Kingdom Growth Medium Sales, by Research K Units (2025-2030)
  • Table 513. Netherlands Growth Medium Sales, by Type K Units (2025-2030)
  • Table 514. Netherlands Growth Medium Sales, by Application K Units (2025-2030)
  • Table 515. Netherlands Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 516. Netherlands Growth Medium Sales, by Research K Units (2025-2030)
  • Table 517. Rest of Europe Growth Medium Sales, by Type K Units (2025-2030)
  • Table 518. Rest of Europe Growth Medium Sales, by Application K Units (2025-2030)
  • Table 519. Rest of Europe Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 520. Rest of Europe Growth Medium Sales, by Research K Units (2025-2030)
  • Table 521. MEA Growth Medium Sales, by Country K Units (2025-2030)
  • Table 522. MEA Growth Medium Sales, by Type K Units (2025-2030)
  • Table 523. MEA Growth Medium Sales, by Application K Units (2025-2030)
  • Table 524. MEA Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 525. MEA Growth Medium Sales, by Research K Units (2025-2030)
  • Table 526. Middle East Growth Medium Sales, by Type K Units (2025-2030)
  • Table 527. Middle East Growth Medium Sales, by Application K Units (2025-2030)
  • Table 528. Middle East Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 529. Middle East Growth Medium Sales, by Research K Units (2025-2030)
  • Table 530. Africa Growth Medium Sales, by Type K Units (2025-2030)
  • Table 531. Africa Growth Medium Sales, by Application K Units (2025-2030)
  • Table 532. Africa Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 533. Africa Growth Medium Sales, by Research K Units (2025-2030)
  • Table 534. North America Growth Medium Sales, by Country K Units (2025-2030)
  • Table 535. North America Growth Medium Sales, by Type K Units (2025-2030)
  • Table 536. North America Growth Medium Sales, by Application K Units (2025-2030)
  • Table 537. North America Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 538. North America Growth Medium Sales, by Research K Units (2025-2030)
  • Table 539. United States Growth Medium Sales, by Type K Units (2025-2030)
  • Table 540. United States Growth Medium Sales, by Application K Units (2025-2030)
  • Table 541. United States Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 542. United States Growth Medium Sales, by Research K Units (2025-2030)
  • Table 543. Canada Growth Medium Sales, by Type K Units (2025-2030)
  • Table 544. Canada Growth Medium Sales, by Application K Units (2025-2030)
  • Table 545. Canada Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 546. Canada Growth Medium Sales, by Research K Units (2025-2030)
  • Table 547. Mexico Growth Medium Sales, by Type K Units (2025-2030)
  • Table 548. Mexico Growth Medium Sales, by Application K Units (2025-2030)
  • Table 549. Mexico Growth Medium Sales, by End Use K Units (2025-2030)
  • Table 550. Mexico Growth Medium Sales, by Research K Units (2025-2030)
  • Table 551. Growth Medium: by Type(USD/Units)
  • Table 552. Research Programs/Design for This Report
  • Table 553. Key Data Information from Secondary Sources
  • Table 554. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Growth Medium: by Type USD Million (2018-2023)
  • Figure 5. Global Growth Medium: by Application USD Million (2018-2023)
  • Figure 6. Global Growth Medium: by End Use USD Million (2018-2023)
  • Figure 7. Global Growth Medium: by Research USD Million (2018-2023)
  • Figure 8. South America Growth Medium Share (%), by Country
  • Figure 9. Asia Pacific Growth Medium Share (%), by Country
  • Figure 10. Europe Growth Medium Share (%), by Country
  • Figure 11. MEA Growth Medium Share (%), by Country
  • Figure 12. North America Growth Medium Share (%), by Country
  • Figure 13. Global Growth Medium: by Type K Units (2018-2023)
  • Figure 14. Global Growth Medium: by Application K Units (2018-2023)
  • Figure 15. Global Growth Medium: by End Use K Units (2018-2023)
  • Figure 16. Global Growth Medium: by Research K Units (2018-2023)
  • Figure 17. South America Growth Medium Share (%), by Country
  • Figure 18. Asia Pacific Growth Medium Share (%), by Country
  • Figure 19. Europe Growth Medium Share (%), by Country
  • Figure 20. MEA Growth Medium Share (%), by Country
  • Figure 21. North America Growth Medium Share (%), by Country
  • Figure 22. Global Growth Medium: by Type USD/Units (2018-2023)
  • Figure 23. Global Growth Medium share by Players 2023 (%)
  • Figure 24. Global Growth Medium share by Players (Top 3) 2023(%)
  • Figure 25. Global Growth Medium share by Players (Top 5) 2023(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Avantor Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Avantor Inc. (United States) Revenue: by Geography 2023
  • Figure 29. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 30. Becton, Dickinson and Company (United States) Revenue: by Geography 2023
  • Figure 31. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2023
  • Figure 33. Caisson Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Caisson Laboratories, Inc. (United States) Revenue: by Geography 2023
  • Figure 35. Cell Culture Technologies LLC (Switzerland) Revenue, Net Income and Gross profit
  • Figure 36. Cell Culture Technologies LLC (Switzerland) Revenue: by Geography 2023
  • Figure 37. Corning Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Corning Inc. (United States) Revenue: by Geography 2023
  • Figure 39. Fujifilm Holdings Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 40. Fujifilm Holdings Corporation (Japan) Revenue: by Geography 2023
  • Figure 41. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 42. GE Healthcare (United States) Revenue: by Geography 2023
  • Figure 43. HiMedia Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 44. HiMedia Laboratories (India) Revenue: by Geography 2023
  • Figure 45. Lonza Group AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 46. Lonza Group AG (Switzerland) Revenue: by Geography 2023
  • Figure 47. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 48. Merck & Co., Inc. (United States) Revenue: by Geography 2023
  • Figure 49. Sartorius AG (Germany) Revenue, Net Income and Gross profit
  • Figure 50. Sartorius AG (Germany) Revenue: by Geography 2023
  • Figure 51. Sera Scandia A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 52. Sera Scandia A/S (Denmark) Revenue: by Geography 2023
  • Figure 53. Global Growth Medium: by Type USD Million (2025-2030)
  • Figure 54. Global Growth Medium: by Application USD Million (2025-2030)
  • Figure 55. Global Growth Medium: by End Use USD Million (2025-2030)
  • Figure 56. Global Growth Medium: by Research USD Million (2025-2030)
  • Figure 57. South America Growth Medium Share (%), by Country
  • Figure 58. Asia Pacific Growth Medium Share (%), by Country
  • Figure 59. Europe Growth Medium Share (%), by Country
  • Figure 60. MEA Growth Medium Share (%), by Country
  • Figure 61. North America Growth Medium Share (%), by Country
  • Figure 62. Global Growth Medium: by Type K Units (2025-2030)
  • Figure 63. Global Growth Medium: by Application K Units (2025-2030)
  • Figure 64. Global Growth Medium: by End Use K Units (2025-2030)
  • Figure 65. Global Growth Medium: by Research K Units (2025-2030)
  • Figure 66. South America Growth Medium Share (%), by Country
  • Figure 67. Asia Pacific Growth Medium Share (%), by Country
  • Figure 68. Europe Growth Medium Share (%), by Country
  • Figure 69. MEA Growth Medium Share (%), by Country
  • Figure 70. North America Growth Medium Share (%), by Country
  • Figure 71. Global Growth Medium: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Avantor Inc. (United States)
  • Becton, Dickinson and Company (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Caisson Laboratories, Inc. (United States)
  • Cell Culture Technologies LLC (Switzerland)
  • Corning Inc. (United States)
  • Fujifilm Holdings Corporation (Japan)
  • GE Healthcare (United States)
  • HiMedia Laboratories (India)
  • Lonza Group AG (Switzerland)
  • Merck & Co., Inc. (United States)
  • Sartorius AG (Germany)
  • Sera Scandia A/S (Denmark)
Additional players considered in the study are as follows:
Thermo Fisher Scientific (United States) , Vitro Diagnostics, Inc. (Denver)
Select User Access Type

Key Highlights of Report


Feb 2024 208 Pages 82 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Growth Medium Quantitative research analysis
Growth Medium Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Avantor Inc. (United States), Becton, Dickinson and Company (United States), Bio-Rad Laboratories, Inc. (United States), Caisson Laboratories, Inc. (United States), Cell Culture Technologies LLC (Switzerland), Corning Inc. (United States), Fujifilm Holdings Corporation (Japan), GE Healthcare (United States), HiMedia Laboratories (India), Lonza Group AG (Switzerland), Merck & Co., Inc. (United States), Sartorius AG (Germany) and Sera Scandia A/S (Denmark) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Investments Across Life Sciences Industry" is seen as one of major influencing trends for Growth Medium Market during projected period 2023-2030.
The Growth Medium market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Growth Medium Report?

Have a Query? Click Here

Other Related Reports

Skin Biopsy Comprehensive Study by Disease Type (Skin Cancer, Actinic Keratosis, Dermatitis, Psoriasis, Fungal Infections, Eczema, Others), Techniques (Shave Biopsy, Punch Biopsy, Wedge Biopsy, Sauce...
$ 3800
Chemotherapy Induced Anemia Comprehensive Study by Drug Type (Androxy Oral, Epoetin Alfa Injection, Epogen Injection, Procrit Injection, Aranesp injection, Others), Type of Anemia (Mild Anemia, Moder...
$ 3750
Pillow Support Systems Comprehensive Study by Type (Neck Pillow, Spinal Support Pillow, Leg Raiser, Knee Support Pillow, V Pillow, Travel Pillow, Others), Application (Image Diagnosis, Surgery, Perso...
$ 3650
Beta Thalassemia Testing Comprehensive Study by Application (Hospitals, Biotechnological Laboratories, Diagnostic Laboratories, Educational Research Institutes, Pharmaceutical Industries), Technology...
$ 2500
Bradycardia Drugs Comprehensive Study by Type (Atropine, Isoproterenol, Aminophylline, Ephedrin, Scopolamine), Application (Sinus Bradycardia, Sinus Cardiac arrest, Sinus Atrial Block, Atrioventricul...
$ 3450
Hospital Acquired Pneumonia Comprehensive Study by Type (Oral Care Kit, Toothbrush, Swab, Moisturizer, Mouth Wash, Suction Tools), End-user (Hospitals, Rehabilitation Centers, Home Care Settings), Dr...
$ 3450